Results 201 to 210 of about 12,617 (217)

An international consensus approach to the management of atypical hemolytic uremic syndrome in children

Pediatric Nephrology, 2015
Martin Bitzan, Anna Bjerre, Diana Karpman   +2 more
exaly  

Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease

Kidney International, 2020
Tessa Gryp, Raymond C Vanholder, F-M Kerckhof   +2 more
exaly  

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2013
Denis Fouque, Bruno Moulin, Giuseppe Remuzzi   +2 more
exaly  

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update

Toxins, 2018
Raymond C Vanholder, Eva Schepers, Griet Glorieux   +2 more
exaly  

Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins

Clinical Science, 2018
Wei Ling Lau, Javad Savoj
exaly  

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

American Journal of Kidney Diseases, 2016
Fadi Fakhouri, Josep M Campistol, Spero R Cataland   +2 more
exaly  

Uremic toxins originating from colonic microbial metabolism

Kidney International, 2009
Pieter Evenepoel, Björn Meijers, Bert Rm Bammens   +2 more
exaly  

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Kidney International, 2016
Larry A Greenbaum, Gianluigi Ardissino, Lars Pape   +2 more
exaly  

Atypical hemolytic uremic syndrome and hypertensive crisis

Kidney International, 2019
Khalil, El Karoui, Idris, Boudhabhay, Véronique, Frémeaux-Bacchi   +2 more
openaire   +2 more sources

Hemolytic uremic syndrome

Seminars in Immunopathology, 2014
Caterina Mele, Giuseppe Remuzzi, Marina Noris   +2 more
exaly